Veris Residential, Inc. Announces Dates for Second Quarter 2025 Financial Results and Webcast
The webcast can be listened to via the Internet by accessing the Company's website at http://investors.verisresidential.com/corporate-overview. The conference call is also accessible by dialing +1 (877) 451-6152 (domestic) or +1 (201) 389-0879 (international) and requesting the Veris Residential second quarter 2025 earnings conference. It is recommended that participants log on or dial in to the call approximately 10 minutes prior to the scheduled start time.
Replay: A replay of the conference call will be available after 12:00 p.m. eastern on Thursday, July 24, 2025 through 11:59 p.m. eastern Sunday, August 24, 2025. To access the replay, listeners may use +1 (844) 512-2921 (domestic) or +1 (412) 317-6671 (international). The passcode for the replay is 13753249. Audio replay from the conference call will also be available on Veris Residential's website at http://investors.verisresidential.com/corporate-overview. The replay will be available on the Company's website for one year after the call date.
About Veris Residential, Inc.Veris Residential, Inc. is a forward-thinking real estate investment trust (REIT) that primarily owns, operates, acquires and develops premier Class A multifamily properties in the Northeast. Our technology-enabled, vertically integrated operating platform delivers a contemporary living experience aligned with residents' preferences while positively impacting the communities we serve. We are guided by an experienced management team and Board of Directors, underpinned by leading corporate governance principles; a best-in-class approach to operations; and an inclusive culture based on meritocratic empowerment.
For additional information on Veris Residential, Inc. and our properties available for lease, please visit https://www.verisresidential.com/.
InvestorsMackenzie RiceDirector, Investor Relationsinvestors@verisresidential.com
MediaAmanda Shpiner/Grace CartwrightGasthalter & Co.212-257-4170veris-residential@gasthalter.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/veris-residential-inc-announces-dates-for-second-quarter-2025-financial-results-and-webcast-302498906.html
SOURCE Veris Residential, Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
18 minutes ago
- Yahoo
Want to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock.
Kenvue is spending big to drum up demand for its diversified product portfolio. The company's weak results reflect pressure on consumer spending. The stock is a good value and has a high yield. 10 stocks we like better than Kenvue › The stock market has historically been a highly effective tool for compounding wealth over time. Another way to use the stock market to achieve your financial goals is to generate income from dividend stocks. Sometimes, it can make sense to target a stodgy company with a high yield, rather than allocate all your savings into high-octane growth stocks. Maybe you're simply looking to diversify, or maybe you're focused on generating a specific amount of dividends to help supplement income in retirement. In that case, it may interest you to know that investing $26,000 into Kenvue (NYSE: KVUE), a high-yield consumer staples stock, could earn you at least $1,000 in dividend income per year. Here's why Kenvue stands out as a solid dividend stock to buy now. In August 2023, Johnson & Johnson spun off its consumer health and hygiene brands under a new publicly traded company called Kenvue. The idea was to allow J&J to focus on its pharmaceutical and medical technology segments, which generally have higher growth prospects than the consumer health division. Kenvue has several well-known brands under categories such as: pain relief and fever (Tylenol, Bengay, etc.) allergy and respiratory (Benadryl, Zyrtec, among others) skin and beauty (Neutrogena, Aveeno, Clean & Clear, etc.) oral health brand (Listerine) baby and child-care brands (Johnson's Baby) digestive health (Lactaid) wound care (Band-Aid and Neosporin) Although established, these brands aren't exactly growing sales at a breakneck pace. It's quite the opposite, in fact. Kenvue's net sales and operating margins have been falling as it struggles to offset inflationary costs and consumer-spending pressures. To make up for the sluggish growth, Kenvue's Vue Forward initiative aims to achieve $350 million in annualized savings by 2026. The company has also been spending a considerable amount on advertising and investing in innovation. In its first quarter, Kenvue launched a variety of marketing campaigns for its biggest brands with social media influencers to appeal to Gen Z consumers. The results led to greater penetration in target markets. So far, however, the ad spending, as a whole, hasn't translated to meaningful bottom-line results. All told, the spinoff hasn't been a success, as measured by Kenvue's results and its underperforming stock price. A major challenge for Kenvue has been private-label brands. Consumers looking to reduce spending may turn to them if they perceive the quality of private-label brands are close enough to name-brand Kenvue items. The threat of private label hurts Kenvue's pricing power, which has been a key differentiator in the consumer staples space among companies that have elite portfolios of brands and can justify price hikes and those that don't. Kenvue has been holding up fairly well despite competition from private-label brands. On its May earnings call, the company said that it hasn't been seeing a shift to private label globally. In fact, private-label penetration in its categories is down slightly. Kenvue's global exposure gives it a unique advantage, compared to companies that are more domestically focused. In its recent quarter, about half of net sales came from North America. The global reach allows the company to offset geographic pressures, such as currency-exchange rates or region-specific changes in consumer behavior. It also drives its brand recognition, which is helping the company hold its own against private-label brands. Kenvue's results have been disappointing, but the stock is a good value and has a high yield. Its forward price-to-earnings ratio (P/E) is just 18.8 at the time of this writing, and its dividend yield is 3.9%. And because Kenvue was spun off from Johnson & Johnson, it inherited its status as a Dividend King -- which is a company that has paid and raised its dividend for at least 50 consecutive years. Kenvue raised its dividend in July of last year, so another raise could be on the way in the coming weeks. Kenvue's nearly two-year stint as an independent company has included a fair share of bumps. The stock is down from its post-split initial price and earnings are trending in the wrong direction. At first glance, Kenvue looks like a stock to avoid, rather than to invest in, but there's arguably a lot of potential for patient investors. The company has an excellent line-up of brands across different product categories and at different price points with a global reach. It hasn't done a good job getting the most out of these brands, but it's also been a challenging operating environment for consumer-focused companies. The consumer staples sector, as a whole, has been selling off as investors gravitate toward higher-growth names amid the broader market rebound. This has pushed companies like Kenvue into the bargain bin. In sum, Kenvue is reasonably valued and offers a generous yield for investors seeking passive income. The stock is worth a closer look for investors who believe in the company's brands, but some individuals may want to take a wait-and-see approach to the stock until management's efforts yield better results. Before you buy stock in Kenvue, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Kenvue wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $671,477!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,010,880!* Now, it's worth noting Stock Advisor's total average return is 1,047% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join . See the 10 stocks » *Stock Advisor returns as of July 14, 2025 Daniel Foelber has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Kenvue. The Motley Fool recommends Johnson & Johnson and recommends the following options: long January 2026 $13 calls on Kenvue. The Motley Fool has a disclosure policy. Want to Generate at Least $1,000 in Passive Income Per Year? Invest $26,000 in This Dividend King Stock. was originally published by The Motley Fool Sign in to access your portfolio
The Verge
22 minutes ago
- The Verge
Grok will no longer call itself Hitler or base its opinions on Elon Musk's, promises xAI
xAI has offered a couple more fixes for 'issues' with its Grok AI chatbot, promising it will no longer name itself 'Hitler' or base its responses on searches for what xAI head Elon Musk has said. According to an X post earlier today, the chatbot's latest update sets new instructions that its responses 'must stem from your independent analysis, not from any stated beliefs of past Grok, Elon Musk, or xAI. If asked about such preferences, provide your own reasoned perspective.' The changes follow more than a week of controversy for Grok. In recent days, multiple reports showed that when asked its opinion about hot-button topics like Israel and Palestine, immigration, and abortion, the chatbot first searched for Musk's opinion on the matter before responding. In its Tuesday post, xAI said that the reason for this was that when asked about its views, 'the model reasons that as an AI it doesn't have an opinion but knowing it was Grok 4 by xAI searches to see what xAI or Elon Musk might have said on a topic to align itself with the company.' The company also addressed another controversy from over the weekend, in which Grok 4 Heavy, the chatbot's $300 per month subscription product, responded that its surname was 'Hitler.' In the company's statement, xAI said that it was due to media headlines responding to yet an earlier incident: Grok going off the rails in a multi-day series of tirades where it denigrated Jews and praised Hitler. (It also posted graphic sexual threats against a user.) Since Grok doesn't have a surname, said xAI, it 'searches the internet leading to undesirable results, such as when its searches picked up a viral meme where it called itself 'MechaHitler.'' The new instructions should prevent this, according to the company. Grok's antisemitism isn't limited to the recent past — in May, the chatbot went viral for casting doubt on Holocaust death tolls. But its responses escalated dramatically this month after a set of changes to its system prompts, including that it should 'assume subjective viewpoints sourced from the media are biased' and that its response 'should not shy away from making claims which are politically incorrect, as long as they are well substantiated.' The 'politically incorrect' instruction was briefly removed before being re-added in recent days. During the livestream release event for Grok 4 last week, Musk said he's been 'at times kind of worried' about AI's intelligence far surpassing that of humans, and whether it will be 'bad or good for humanity.' 'I think it'll be good, most likely it'll be good,' Musk said. 'But I've somewhat reconciled myself to the fact that even if it wasn't going to be good, I'd at least like to be alive to see it happen.' Now, xAI says that after rolling out these latest updates, the company is 'actively monitoring and will implement further adjustments as needed.'
Bloomberg
22 minutes ago
- Bloomberg
Santander's Botin on US Consumer, Europe and Stablecoins
Banco Santander Executive Chair Ana Botin says she sees "tremendous opportunity" in the US market. Speaking with Sonali Basak on "Bloomberg Markets," Botin discusses the state of the US consumer, what she sees as upside potential in Europe and the outlook for stablecoin adoption. (Source: Bloomberg)
